Norland’s Paris scanner hits market

Bone densitometry firm Norland Medical Systems continues to make progress in rolling out its Paris ultrasound bone measurement system. The company has begun delivery of Paris systems to European and Pacific Rim customers, and is shipping Paris to physician investigators for testing as part of the Food and Drug Administration's premarket approval process. Norland expects to file its PMA this quarter.

In other company news, Norland has received FDA 510(k) clearance to market a fracture risk assessment feature for its pDEXA x-ray peripheral bone densitometer. Physicians can use the feature to select patients who might benefit from preventive treatment to avoid fractures, as well as to make clinical decisions regarding therapeutic intervention, according to White Plains, NY-based Norland.